Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Elisabeth Nielsen-Hannerup"'
Autor:
Maurice A Lembeck, Hanne Pedersen, Ellen Astrid Holm, Emilie Ramberg, Kirstine Dahmke, Elisabeth Nielsen-Hannerup, Ida Søndergaard Madsen, Sofie Rerup
Publikováno v:
BMJ Open, Vol 12, Iss 3 (2022)
Objective Most previous studies on advance care planning (ACP) have focused on patients with specific diseases and only a few on frail ageing individuals. We therefore decided to examine the perspective of geriatric patients on ACP. Our research ques
Externí odkaz:
https://doaj.org/article/d24877a95570477aa67c5c0f9aa3042d
Autor:
Elisabeth Nielsen-Hannerup, Filip K. Knop, Tina Vilsbøll, Sofie Hædersdal, Henrik Maagensen, Gerrit van Hall, Asger Lund, Jens J. Holst
Publikováno v:
Diabetes
Sodium–glucose cotransporter 2 inhibitors (SGLT2i) effectively lower plasma glucose (PG) concentration in patients with type 2 diabetes, but studies have suggested that circulating glucagon concentrations and endogenous glucose production (EGP) are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7aff035e14f977810a8bf0bf1699dc74
https://doi.org/10.2337/db20-0369
https://doi.org/10.2337/db20-0369
Autor:
Sofie Hædersdal, Asger Lund, Henrik Maagensen, Elisabeth Nielsen-Hannerup, Lærke S Gasbjerg, Mette M Rosenkilde, Julie L Forman, Gerrit van Hall, Jens J Holst, Filip K Knop, Tina Vilsbøll
Publikováno v:
European journal of endocrinology. 186(2)
Objective Type 2 diabetes (T2D) pathophysiology includes fasting and postprandial hyperglucagonemia, which has been linked to hyperglycemia via increased endogenous glucose production (EGP). We used a glucagon receptor antagonist (LY2409021) and stab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f4b879d2fc99a5c76d14d7a3c9b55c2
https://pubmed.ncbi.nlm.nih.gov/34863038
https://pubmed.ncbi.nlm.nih.gov/34863038
Autor:
Kirstine Dahmke, Elisabeth Nielsen-Hannerup, Ida Søndergaard Madsen, Sofie Rerup, Emilie Ramberg, Maurice A Lembeck, Hanne Pedersen, Ellen Astrid Holm
Publikováno v:
Dahmke, K, Nielsen-Hannerup, E, Madsen, I S, Rerup, S, Ramberg, E, Lembeck, M A, Pedersen, H & Holm, E A 2022, ' Perspective of geriatric patients on advance care planning in Denmark : a qualitative study ', BMJ Open, vol. 12, no. 3, 056115 . https://doi.org/10.1136/bmjopen-2021-056115
ObjectiveMost previous studies on advance care planning (ACP) have focused on patients with specific diseases and only a few on frail ageing individuals. We therefore decided to examine the perspective of geriatric patients on ACP. Our research quest
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dace5cd567bfd4274d5b7036ab2c4706
https://doi.org/10.1136/bmjopen-2021-056115
https://doi.org/10.1136/bmjopen-2021-056115
Autor:
Tina Vilsbøll, Filip K. Knop, Jens J. Holst, Gerrit van Hall, Henrik Maagensen, Elisabeth Nielsen-Hannerup, Asger Lund, Sofie Hædersdal, Ada Admin
Sodium-glucose cotransporter 2 (SGLT2) inhibitors (SGLT2i) effectively lower plasma glucose (PG) concentration in patients with type 2 diabetes, but studies suggest that circulating glucagon concentrations and endogenous glucose production (EGP) are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db2afd85fad437500735bda3100017bb
https://doi.org/10.2337/figshare.13010123
https://doi.org/10.2337/figshare.13010123
Autor:
Tina Vilsbøll, Asger Lund, Elisabeth Nielsen-Hannerup, Filip K. Knop, Jens J. Holst, Sofie Hædersdal, Henrik Maagensen
Publikováno v:
Diabetes. 67
Studies suggest that sodium-glucose cotransporter 2 inhibitors (SGLT2i) induce hyperglucagonemia, which might counteract its glucose-lowering ability in type 2 diabetes. In a randomized, placebo-controlled, double-dummy, double-blinded, cross-over st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cb311e790bea65035b2e8288ef47fce3
https://doi.org/10.2337/db18-1942-p
https://doi.org/10.2337/db18-1942-p